Granulocyte-colony-stimulating Factor for Acute Ischemic Stroke: A Randomized Controlled Trial (STEMTHER)

Translational Stroke Research

Volumn 2, Issue 3, 2011, Pages 358-365

  Alasheev, Andrey Marisovich ^a,b,c   Belkin, Andrey Avgustovich ^a,b,c   Leiderman, Ilya Naumovich ^a,b,c   Ivanov, Roman Alekseyevich ^b   Isakova, Tatyana Mikhailovna ^c  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b Institute of Medical Cell Technologies   (Russian Federation)

^c The Sverdlovsk Regional Stroke Centre   (Russian Federation)

Author keywords

Colony stimulating factors; Filgrastim; Ischemic stroke; Randomized clinical trial; Stem cells

Indexed keywords

LEUKOSTIM; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLEEDING; BRAIN ISCHEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DYSPNEA; EDEMA; FEMALE; FEVER; HOSPITAL INFECTION; HUMAN; HYPERLEUKOCYTOSIS; INFARCTION; INJECTION SITE PAIN; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MOTOR PERFORMANCE; MUSCULOSKELETAL PAIN; NAUSEA; PERICARDIAL EFFUSION; PRIORITY JOURNAL; RANKIN SCALE; SPLENOMEGALY; SUPRAVENTRICULAR TACHYCARDIA; THROMBOCYTE COUNT; TREATMENT OUTCOME; VASCULITIS; VOMITING;

EID: 80052274087     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-011-0091-3     Document Type: Article

References (19)

1. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008; 371: 1612-23.
2. Borlongan CV, Hess DC. New hope for stroke patients: mobilization of endogenous stem cells. CMAJ. 2006; 174: 954-5.
3. Solaroglu I, Cahill J, Jadhav V, Zhang JH. A novel neuroprotectant granulocyte-colony stimulating factor. Stroke. 2006; 37: 1123-8.
4. Grigg AP, Roberts AW, Raunow H, Houghton S, Layton JE, Boyd AW, et al. Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood. 1995; 86: 4437-45.
5. Shyu WC, Lee YJ, Liu DD, Lin SZ, Li H. Homing genes, cell therapy and stroke. Front Biosci. 2006; 11: 899-907.
6. England TJ, Gibson CL, Bath PM. Granulocyte-colony stimulating factor in experimental stroke and its effects on infarct size and functional outcome: a systematic review. Brain Res Rev. 2009; 62: 71-82.
7. Paczkowska E, Larysz B, Rzeuski R, Karbicka A, Jałowiński R, Kornacewicz-Jach Z, et al. Human hematopoietic stem/progenitor-enriched CD34(+) cells are mobilized into peripheral blood during stress related to ischemic stroke or acute myocardial infarction. Eur J Haematol. 2005; 75: 461-7.
8. D'Souza A, Jaiyesimi I, Trainor L, Venuturumili P. Granulocyte colony-stimulating factor administration: adverse events. Transfus Med Rev. 2008; 22: 280-90.
9. Zohlnhöfer D, Dibra A, Koppara T, de Waha A, Ripa RS, Kastrup J, et al. Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis. J Am Coll Cardiol. 2008; 51: 1429-37.
10. Schäbitz WR, Laage R, Vogt G, Koch W, Kollmar R, Schwab S, et al. AXIS. A trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. Stroke. 2010; 11: 2545-51.
11. Shyu WC, Lin SZ, Lee CC, Liu DD, Li H. Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial. CMAJ. 2006; 174: 927-33.
12. Sprigg N, Bath PM, Zhao L, Willmot MR, Gray LJ, Walker MF, et al. Granulocyte-colony-stimulating factor mobilizes bone marrow stem cells in patients with subacute ischemic stroke: the Stem cell Trial of recovery EnhanceMent after Stroke (STEMS) pilot randomized, controlled trial (ISRCTN 16784092). Stroke. 2006; 37: 2979-83.
13. Olsen TS, Langhorne P, Diener HC, Hennerici M, Ferro J, Sivenius J, et al. European stroke initiative recommendations for stroke management-update 2003. Cerebrovasc Dis. 2003; 4: 311-37.
14. Gratama JW, Sutherland DR, Keeney M, Papa S. Flow cytometric enumeration and immunophenotyping of hematopoietic stem and progenitor cells. J Biol Regul Homeost Agents. 2001; 15: 14-22.
15. Kröger N, Renges H, Krüger W, Gutensohn K, Löliger C, Carrero I, et al. A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation. Br J Haematol. 2000; 111: 761-5.
16. D'Erasmo E, Acca M, Medici F, Pisani D. Clinical aspects of early increase in serum gamma-glutamyl transferase in cerebral infarction. Biomed Pharmacother. 1993; 47: 89-92.
17. Kurzepa J, Bielewicz J, Stelmasiak Z, Bartosik-Psujek H. Serum bilirubin and uric acid levels as the bad prognostic factors in the ischemic stroke. Int J Neurosci. 2009; 119: 2243-9.
18. Hüttmann A, Dührsen U, Stypmann J, Noppeney R, Nückel H, Neumann T, et al. Granulocyte colony-stimulating factor-induced blood stem cell mobilisation in patients with chronic heart failure-feasibility, safety and effects on exercise tolerance and cardiac function. Basic Res Cardiol. 2006; 101: 78-86.
19. Pineda S, Bang OY, Saver JL, Starkman S, Yun SW, Liebeskind DS, et al. Association of serum bilirubin with ischemic stroke outcomes. J Stroke Cerebrovasc Dis. 2008; 17: 147-52.